ANI Pharmaceuticals, Inc. announced FDA approval of its oral Valproic Acid generic (ANDA073178), a development that further diversifies the company's product portfolio and strengthens its competitive position within the established generics market.
ANI Pharmaceuticals, Inc. announced FDA approval of its oral Valproic Acid generic (ANDA073178), a development that further diversifies the company's product portfolio and strengthens its competitive position within the established generics market.